// App-Quantinova.ai

POS1028 (2022) : GUSELKUMAB MAINTAINS RESOLUTION OF DACTYLITIS AND ENTHESITIS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS THROUGH 2 YEARS FROM A PHASE 3 STUDY

Researchers

Presenter

  • P. Rahman

Principal Investigators

  • I. Mcinnes

  • A. Deodhar

  • G. Schett

  • P. J. Mease

  • M. Shawi

  • D. Cua

  • J. Sherlock

  • A. Kollmeier

  • X. L. Xu

  • Y. Jiang

  • S. Sheng

  • C. T. Ritchlin

  • D. Mcgonagle

Medical Centers

  • Memorial University of Newfoundland, Discipline of Medicine, St. Johns, Newfoundland, Canada

  • University of Glasgow, Institute of Infection Immunity and Inflammation, Glasgow, United Kingdom

  • Oregon Health and Science University, Rheumatology Clinica Division of Arthritis and Rheumatic Diseases, Portland, United States of America

  • FAU Erlangen-Nuremburg and Universitatsklinikum, Internal Medicine 3, Erlangen, Germany

  • 2Swedish Medical Center/Providence St. Joseph Health and University of Washington, Rheumatology, Seattle, Washington, United States of America

  • Janssen Global Services, LLC, Global Medical Affairs, Horsham, PA, United States of America

  • Janssen Research and Development, LLC, Department of Immunology, San Diego, CA, United States of America

  • University of Oxford, Oxford, United Kingdom

  • Janssen Research and Development, LLC, Department of Immunology, San Diego, CA, United States of America

  • University of Rochester, Allergy/Immunology and Rheumatology, Rochester, United States of America

  • Leeds Biomedical Research Centre University of Leeds, Rheumatology, Leeds, United Kingdom

Locations

  • Canada

  • United Kingdom

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Musculoskeletal

  • Dermatology

Disease

  • Psoriatic arthritis

  • Dactylitis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • guselkumab (IV)

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • III

Study Id's

  • N/A

Sponsors

  • Janssen and Novartis

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved